Bcl-2 expression is moderately correlated with long-term variability of CD4 T-cell increase under successful highly active antiretroviral therapy
- 1 January 2003
- journal article
- other
- Published by Ovid Technologies (Wolters Kluwer Health) in AIDS
- Vol. 17 (1), 141-143
- https://doi.org/10.1097/00002030-200301030-00027
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Involvement of Bcl-2 and IL-2R in HIV-positive patients whose CD4 cell counts fail to increase rapidly with highly active antiretroviral therapyAIDS, 2002
- Naive CD4+T Lymphocytes Express High Levels of Bcl-2 after Highly Active Antiretroviral Therapy for HIV InfectionAIDS Research and Human Retroviruses, 2000
- Repeated measures in clinical trials: simple strategies for analysis using summary measuresStatistics in Medicine, 2000
- Prediction of Imminent Complications in HIV-1–Infected Patients by Markers of Lymphocyte ApoptosisJAIDS Journal of Acquired Immune Deficiency Syndromes, 2000
- Highly active anti-retroviral therapy (HAART) is associated with a lower level of CD4+ T cell apoptosis in HIV-infected patientsClinical and Experimental Immunology, 1999
- Study of Spontaneous Apoptosis in HIV+Patients: Correlation with Clinical Progression and T Cell LossAIDS Research and Human Retroviruses, 1997